1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Ireland Pharmaceuticals and Healthcare Report Q4 2016

Ireland Pharmaceuticals and Healthcare Report Q4 2016

  • September 2016
  • -
  • Business Monitor International
  • -
  • 75 pages

Includes 3 FREE quarterly updates

BMI View:

The Irish government's four-year agreement with the pharmaceutical industry with regard todrug pricing reflects the government's continued focus on cost control measures targeting pharmaceuticalexpenditure. The agreed price-reduction mechanism for existing medicines will, however, allow for theprioritisation of funding toward ensuring access to new, innovative medicines. While the pharmaceuticalmarket will continue to decline in value terms, Ireland's robust long-term economic outlook will continue tosupport healthcare expenditure expansion. Rising demand for healthcare will be reflected in rising privatehealth insurance uptake.

Headline Expenditure Projections


- Pharmaceuticals: EUR2.32bn (USD2.53bn) in 2015 to EUR2.27bn (USD2.50bn) in 2016;-2.0% in localcurrency terms and -1.0% in US dollar terms. Forecast in line in local currency terms and revisedupwards in US dollar terms from last quarter.

- Healthcare: EUR15.08bn (USD16.42bn) in 2015 to EUR15.48bn (USD17.03bn) in 2016; +2.7% in localcurrency terms and 3.7% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Ireland Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Ireland 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Ireland 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Ireland 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Ireland 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Ireland 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Ireland 2012-2020) 21
OTC Medicine Market Forecast 22
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Ireland 2012-2020) 23
Pharmaceutical Trade Forecast 24
Table: Top 15 Pharmaceuticals and Healthcare Export Companies In 2013 26
Table: Pharmaceutical Trade Data And Forecasts (Ireland 2014-2020) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Ireland 2014-2020) 27
Industry Risk/Reward Index 28
Western Europe Risk/Reward Index 28
Ireland Risk/Reward Index 34
Rewards 34
Risks 35
Regulatory Review 36
Intellectual Property Issues 40
Pricing Regime 41
Reimbursement Regime 43
Market Overview 47
Healthcare Sector 48
Table: Health Status 51
Table: Healthcare Funding 52
Table: Healthcare Resources (Ireland 2010-2015) 52
Table: Healthcare Personnel (Ireland 2010-2015) 52
Table: Healthcare Activity (Ireland 2010-2015) 53
Research and Development 53
Clinical Trials 54
Epidemiology 56
Competitive Landscape 58
Research-Based Industry 58
Table: Multinational Market Activity 60
Table: Pharmaceutical Companies In Ireland 61
Generic Drugmakers 62
Pharmaceutical Distribution 63
Demographic Forecast 64
Table: Population Headline Indicators (Ireland 1990-2025) 65
Table: Key Population Ratios (Ireland 1990-2025) 65
Table: Urban/Rural Population and Life Expectancy (Ireland 1990-2025) 66
Table: Population By Age Group (Ireland 1990-2025) 66
Table: Population By Age Group % (Ireland 1990-2025) 67
Glossary 69
Methodology 71
Pharmaceutical Expenditure Forecast Model 71
Healthcare Expenditure Forecast Model 71
Notes On Methodology 72
Risk/Reward Index Methodology 73
Index Overview 74
Table: Pharmaceutical Risk/Reward Index Indicators 74
Indicator Weightings 75

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

This report on the poultry pharmaceuticals market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.